Derma Sciences, Inc. (DSCI) CEO Highlights Rapid Growth of MEDIHONEY Products in Presentation at Comvita Annual Meeting
7/25/2013 8:17:14 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces that its chief executive officer, Edward J. Quilty, highlighted the rapid growth of MEDIHONY® Dressings with medical grade Manuka (Leptospermum) Honey, and the rewarding relationship between Derma Sciences and Comvita Limited in a presentation at Comvita’s annual shareholders’ meeting in New Zealand yesterday.
Help employers find you! Check out all the jobs and post your resume.
comments powered by